Widely regarded as the premier gathering for the food and drug law community, the FDLI Annual Conference offers an unparalleled opportunity to explore the complex legal, regulatory, compliance, and policy issues shaping the FDA-regulated industry.
This year's program features more than 30 sessions and 100 distinguished speakers. Reed Smith Partner Sarah Thompson Schick will present during a session titled "AI, Devices, and Drug Development: Model Behavior in Medical Products," exploring AI policy, NAMs, and digital tools across drug development and device regulation.
In addition to Sarah's presentation, several Reed Smith partners will be in attendance, including Rebecca (Becca) Jones McKnight, Cori Annapolen Goldberg, and Sung Park.
